10.12.2009
MagForce Nanotechnologies AG appoints Dr. Peter Heinrich as Chief Executive Officer
Berlin – MagForce Nanotechnologies AG (Entry Standard segment of the Frankfurt Stock Exchange, ticker MF6) has announced the appointment of Dr. Peter Heinrich, until now the deputy chairman of its supervisory board, as the company’s new chief executive officer effective January 1, 2010. The ...
10.12.2009
Professor Wolfgang Heckl appointed to supervisory board of MagForce Nanotechnologies AG
Berlin – Professor Wolfgang Heckl has been newly appointed as a supervisory board member of MagForce Nanotechnologies AG (Entry Standard segment of the Frankfurt Stock Exchange, ticker MF6), following the election of Dr. Peter Heinrich, until now deputy chairman of the supervisory board, as the new ...
03.11.2009
MagForce Nanotechnologies reaches primary study endpoint in pivotal glioblastoma study
Berlin - MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. The primary study endpoint, which was to extend the median survival time following tumor ...
22.09.2009
MagForce Nanotechnologies completes patient recruitment for pivotal glioblastoma study
Berlin – MagForce Nanotechnologies AG has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer® therapy. The results of this phase II clinical trial will serve as the basis ...
27.08.2009
Berlin mayor Klaus Wowereit visits MagForce Nanotechnologies
Berlin - Klaus Wowereit, who as Governing Mayor of Berlin serves as both mayor of the city and governor of the state, today visited MagForce Nanotechnologies AG along with representatives of the press corps. Following a company presentation and a guided tour through MagForce’s new office and ...
03.06.2009
MagForce Nanotechnologies fulfills key European ISO standard for the development, manufacturing, final inspection and distribution of products used for its Nano-Cancer® therapy
Berlin - MagForce Nanotechnologies AG has received certification according to European Norm (EN) ISO 13485:2003 + AC:2007. As part of its audit, Medcert GmbH, the medical certification and testing company, examined the quality management systems of MagForce in the areas of development, ...
11.02.2009
German Federal Minister Wolfgang Tiefensee Visits MagForce Nanotechnologies
Berlin – As a prelude to the "Future Conference on Nanotechnology" to be held in the German capital of Berlin on February 19, German federal minister for transport, building and urban affairs Wolfgang Tiefensee, who also serves as federal commissioner for the new German states, today ...